Dr. Daisy Shu is a Scientia Senior Lecturer in the School of Optometry and Vision Science at the University of New South Wales in 2023. The Shu lab explores the role of mitochondria and metabolism in retinal eye diseases including age-related macular degeneration and proliferative vitreoretinopathy. She is focused on the molecular mechanisms of epithelial-mesenchymal transition and endothelial-mesenchymal transition in lens and retinal disease. Dr. Shu is the course convener for OPTM6423 (Therapeutics and the Posterior Eye) for Masters Optometry students. Dr. Shu graduated with a Bachelor of Optometry and Vision Science in 2012 from UNSW Sydney and a PhD in 2019 at the University of Sydney under the mentorship of Prof. Frank Lovicu, concentrating on growth factor signaling pathways in cataract formation. Dr. Shu completed her postdoctoral training in molecular mechanisms underpinning age-related macular degeneration under the mentorship of Dr. Magali Saint-Geniez at Harvard Medical School in 2022 and was promoted to Faculty Instructor in the Department of Ophthalmology of Harvard Medical School at Schepens Eye Research Institute of Mass Eye and Ear.
Dr. Shu serves many leadership roles including Vice President for International Society of Eye Research (ISER) for the Asia-Pacific Region and serves on several committees including the ARVO Board of Trustees, ARVO Women in Eye and Vision Research (WEAVR) Leadership Committee, ARVO Professional Development and Education Committee and the ASIP Committee for Career Development. Daisy is passionate about science communication and science advocacy. Her advocacy efforts have been recognized by the ARVO Emerging Advocate Award in 2021. She co-hosts a podcast called “Behind Our Science” supported by ASIP and The Histochemical Society and actively updates her social media platforms @EyeDaisyShu on Twitter and Instagram.
2019: Shu DY. Cancer Research Foundation Cell Imaging Grant for the EVOS M7000 Imaging System (AMF7000), USD$78, 315, Thermo Fisher Scientific
July 2020 – July 2021: Shu DY. Fight for Sight Leonard & Robert Weintraub Postdoctoral Fellowship, USD$22, 500. Fight for Sight United States
July 2021 – July 2023: Shu DY. Postdoctoral Fellowship Program in Macular Degeneration Research, USD$200, 000. BrightFocus Foundation
2022-2022: Shu DY. Interstellar Initiative by the Japan Agency for Medical Research and Development (AMED) and the New York Academy of Sciences. The initiative aims to increase international and interdisciplinary collaboration uniting scientists within the early stages of their careers and catalyzing scientific advancement 2700000JPY (18598USD). nyas.org/interstellar
2023-2026: Kim LA & Shu DY. The Role of the Rho-Kinase Pathway in Proliferative Vitreoretinopathy. Department of Defence Congressionally Directed Medical Research Programs Vision Research Program Investigator-Initiated Research Award ($500K USD)
My online NCBI Bibliography can be accessed here.
Course Convener for OPTM6423 Therapeutics and the Posterior Eye